SUBMITTED BY – NIHAL TYAGI SUBMITTED TO – SHAGUN MA’AM

ROLL NO - PGP24146
SECTION - C
 INTRODUCTION OF SUN PHARMA

Sun Pharma is a pharmaceutical  The company was founded in 1983

company headquartered in Mumbai,  IT has since grown to have a presence in over 150 countries.

India.

It is one of the largest pharmaceutical

companies in India and the fifth-largest

specialty generic company in the world.

 Sun pharma social presence

27K 3K 576 19.8K

 Social media presence

Competitors Sunpharma Cipla Dr.reddy Aurbindo LIPIN

FACEBOOK 34K 75K 195K 27L 23K

TWITTER 27.2K 32.8K 32.4K 1071 6914

LINKEDLN 993K 1M 841K 92K 210K

YOU TUBE 9.7K 9.22K 7.56K 2.78K 2

INSTAGRAM 576 11.8K 10.8K 451 56

 FREQUENCY ANALYSIS

PLATFORMS FREQUENCY OF POST Last post was on

INSTAGRAM 2 post per month 2- feb 2023

FACEBOOK 4 times a month. 2-feb-2023

YOUTUBE 2 videos per Month 2-feb-2023

TWITTER 1 tweet in every two days 2-feb-2023

LINKEDIN 4 times a month. 2-feb-2023

 Theme of sun pharma

 They post similar posts on Facebook as of LinkedIn but another additional factor was video messages from
their CEO, Chairman, and Directors. They post one post per week on Facebook.
 Twitter - they tweet one tweet in every two days, conduct quiz, inform about their research contest winners,
and basic health knowledge.
 LinkedIn - they post about their achievement, work culture, quiz about their knowledge of medicine and
they post 4 times a month.
 Youtube - 2 videos per month which include topics like – world health day doctor day Breastfeeding week,
leadership insights, and covid related health videos.
 Theme of competitor

 Focus on the level of exposure

 Onboarding of new employees
 Health-related festivals
 Sustainability
 Achievements
 SALES AND REVENUE OF FY2022

1. They have sales of 3,84,264 Million sales in the year 2022 and a net profit is around 32,727 million.

2. The sales in India are 127,593 million which shows 1/3 of business sales are from India
Web analysis of sun-pharma
Social media traffic to Sun-Pharma
Competitor’s Analysis
 SWOT ANALYSIS

STRENGTHS WEAKNESSES

1. Strong growth in emerging market 1. Stiff competition from many Indian

business and other global brands means
limited market share growth
2. They have strong marketing & sales
force of over 12,000 employees
2. Limited presence in emerging
3. They have successfully acquired Taro markets and European countries
pharma which has further consolidated
their position in Indian markets

4. Strong brand presence in India and

US markets
 SWOT ANALYSIS

OPPORTUNITIES THREATS

1.There is growing competition in the

1. They can leverage their acquisitions
to further increase the growth
2. They can increase their presence in
contract manufacturing.
generics market
2. Stringent patent regulations.
3. High price sensitivity of consumers

3. Increasing healthcare awareness in

India
 PESTEL
ANALYSIS

POLITICAL :
 Taxation policies – Over the last two decades Sun Pharma has benefitted from lower taxation policies
throughout the western hemisphere.
 The government of India has come under increasing global pressure to adhere to World Trade Organization’s
regulations on Biotechnology & Drugs industry.

ECONOMIC:
 The efficiency of financial markets in India – Sun Pharma can access vibrant financial markets and easy
availability of liquidity in the equity market of India to expand further globally.
.

PESTEL

SOCIAL:
 Access to essential services – By and large over the last decade and half the wider population in
gotten access to essential services in India.
 It should strive to build a local team that understands the societal norms and attitudes better to
serve the customers in India
TECHNOLOGY :
 Latest technology based innovations implemented by competitors of Sun Pharma – This can
provide a good insight into what the competitors are thinking and where Biotechnology & Drugs
business model future is.
 PESTEL

ENVIRONMENT:
 Regular scrutiny by environmental agencies is also adding to the cost of operations of Sun Pharma –
 Recycling is fast emerging as a norm rather than a good thing to do in India’s economy. Sun Pharma has to
make plans to adhere to regulations and expectations in the Healthcare sector.

LEGAL :
 Environment Laws and guides – The level of environmental laws in the India and what Sun Pharma needs to
do to meet those laws and regulations.
 Sun Pharma has to consider whether India have a robust mechanism to protect against data breaches or not.